DocMorris AG
LSE 0RRB.L
DocMorris AG EBIT for the year ending December 31, 2023: USD -116.40 M
-
DocMorris AG EBIT for the year ending December 31, 2022 was USD -161.59 M, a 29.53% change year over year.
-
DocMorris AG EBIT for the year ending December 31, 2021 was USD -229.32 M, a -77.82% change year over year.
-
DocMorris AG EBIT for the year ending December 31, 2020 was USD -128.96 M, a -182.37% change year over year.
-
DocMorris AG EBIT for the year ending December 31, 2019 was USD -45.67 M, a -23.18% change year over year.
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
| CEO | Mr. Walter Hess |
| IPO Date | Sept. 12, 2017 |
| Location | Switzerland |
| Headquarters | WalzmUehlestrasse 60 |
| Employees | 1,453 |
| Sector | Health Care |
| Industries | |
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Past 5 years
USD 0.02
USD 2.69
StockViz Staff
January 15, 2025
Any question? Send us an email